chosen to carry out trials of the chinese vaccine and next week, johnson & johnson with the united states vaccinerazeneca vaccine. there is also a german vaccine. everyone is willing to do the tests here and that is a good thing because it will mean we know how our people will react. >> cases in peru recently surpassed 800,000, one of the highest rates in the world. though there are signs that contagion has slowed, experts say self-isolation and social distancing are necessary. >> this decrease means everything ended, if people let their guard down, the people that have been cautious let this guard down and start to go out, they expose themselves. we could see a second wave. >> a lifting of restrictions has meant cemeteries are allowing visits from family members who have lost loved ones to the virus. peru has recorded more than 32,000 deaths from covid-19, representing the third highest death toll in latin america. more than 40% of argentina's population has been dragged into poverty. the five percentage point increase was announced by the official statistics agency, being attributed to the impa

out trials of the chinese vaccine and starting next week this johnson and johnson with the united states vaccine and also the astra zeneca vaccine from the united kingdom there is also a german vaccine everyone is willing to do the clinical tests here and that is a good thing because it will mean we know how our own people will react coronavirus cases in peru recently surpassed 800000 which is one of the highest contagion rates in the world and although there are signs the contagion has slowed experts say that self isolation and social distancing are still necessary illegally this risk is thinking that this decrease means that everything ended if people let their guard down the people that have been cautious let their guard down and start to go out they begin to expose themselves we could see what's called a 2nd wave if a lifting of restrictions in the country has also meant cemeteries are now allowing visits from family members who have lost loved ones. to the virus peru has recorded more than 32000 deaths from pope at 19 representing the 3rd highest death toll in latin america. al-jazeera. u.s

is a chance they could roll out this vaccine in time to get the elderly population in the united states vaccinatedey need to wait a month to get the second dose until they have protective immunity from the vaccine. you're looking at 2021 until the immunity kicks in. i think it is unrealistic to think we'll have a vaccine widely available for general distribution and authorized by the f.d.a. until probably the second quarter of 2021. >> brennan: understood. thank you, dr. gottlieb. we'll be back in a moment. when you humble yourself under the mighty hand of god, in due time he will exalt you. hi, i'm joel osteen. i'm excited about being with you every week. i hope you'll tune in. you'll be inspired, you'll be encouraged. i'm looking forward to seeing you right here. you are fully loaded and completely equipped for the race that's been designed for you. >> brennan: as part of our continuing efforts to hear from voters in the coronavirus pandemic, on friday night we zoomed with six voters, evenly divided on their voting preference. they were also divided on their thoughts about the impact of the viru

out trials of the chinese vaccine and starting next week this johnson and johnson with the united states vaccine and also the astra zeneca vaccine from the united kingdom there is also a german vaccine everyone is willing to do the clinical tests here and that's a good thing because it will mean we know how our own people will react coronavirus cases in peru recently surpassed 800000 which is one of the highest contagion rates in the world and although there are signs the contagion has slowed experts say that self isolation and social distancing are still necessary iliza least risk is thinking that this decrease means that everything ended if people let their guard down the people that have been cautious let their guard down and start to go out they begin to expose themselves we could see what's called a 2nd wave. a lifting of restrictions in the country has also meant cemeteries are now allowed. visits from family members who have lost loved ones to the virus peru has recorded more than 32000 deaths from hope at 19 representing the 3rd highest death toll in latin america. al-jazeera. child marr

vaccine could be taking a new turn. but there is debate over the strategy and possible ethical concerns. across the united states covid vaccine trials are stretching toward the finish line now after months of patients receiving vaccines or placebos and returning home. but what if researchers could speed that process up by exposing them to the virus deliberately? it's known as a human challenge trial. >> you need less people because you can do hundreds of people instead of thousands because you know you're going to give them the infection. >> reporter: and now the uk has just approved its first human challenge trial for covid. while the technique is less common in the united states, a movement has been building in congress. representative bill foster of illinois co-authored a letter to health and human services asking it to consider challenge trials to speed vaccine development. >> so scientifically it's much more controlled than the large clinical trials where you get 30,000 people, you vaccinate half of them, you get the dummy vaccine. to the other half of them. and then you just wait. >> reporter: examples dat

of riots in italy, multiple governance in the united states saying we are not sure if the fda gives an emergency use authorization or approval letter vaccineould be a thing is so shocking. i'm confident the united states will have a vaccine, 50 million doses by the end of this calendar year. the election is an artificial deadline that does not have any bearing on when a vaccine is produced in the united states has repurchased 500 million doses. and the for every american that they will be receiving. we will prioritize front-line workers including military, medical workers and so forth and the public will have vaccines from march on word. that is from my reading and my estimation but if we have four governors have announced, governor cuomo, governor newsom, washington in nevada, the first death of coronavirus in the united states were reporting, first nursing home outbreak was reported. putting up barriers saying they have a safety committee born before releasing it in the population, let me tell you nobody can replicate what the fda does and true safety won't be known until we have tens of millions of people vaccinated around the world. we

outside the norms but not daily and looking at vaccine for the entire united states we need a robust plan, people that will raise their hands to want to do this, a willing healthcare supply chain to do this. a matter of becoming collaborative together, communicate among each other and execute on a plan we can all agree upon in order to get the vaccine to patients, not just to approval but to patients, what we need to focus on. >> joshua sharfstein, one of the realities we are seeing is incredible time pressure put on science, the industry, the innovators trying to discover a vaccine and manufacture and distribute it. at the same time a lot of politicking, this is the time of an election and there are concerns about trusting the -- is science able to give the leeway it needs to produce what it should do or are we taking shortcuts? you have 5 on pressure on the fda and others but i will ask a similar question. should we all be able to trust what is developing? >> trust comes from expertise, people who know what they are doing are making good decisions. it comes from data, transparency,

but the reopening fresh restrictions in europe, and in the united states. vaccineatment news mixed recently earnings improving, but the bottom line is we're off to a good start on earnings 41 companies reporting, 8% of the s&p 500 overall now, 85% above expectations, 29% the average, that's the huge number. great start to earnings season here is the conundrum, even though third quarter and the fourth quarter numbers are looking good, large earnings beats may be priced in we had a huge run-up first half of october, on all of this news. we have been reporting this here the guidance we're expecting, we're hoping to come from companies, i don't think it is going to come. i think the corporations are restrained by the reopening story, the vaccine story and stimulus story a collar around the market now on that guidance that you need from the companies i want to note something, very famed value investor ted aronsohn, very well known as an investor in value is closing his shop $10 billion, it was $30 billion, you know, david, this may be one of the bell ringing moments, he

vaccine as well. we are not trying to politicize. the president of the united states has politicized this vaccine coming just weeks before an election. we owe it to the american people to explain the process and the system and the transparency in the hopes that one of these multiple vaccine candidates will be proven safe and effective. that will be only half the battle. once we have unapproved vaccine, we still face the formidable challenge of distributing hundreds of millions of doses around the country. this will be an unprecedented effort and we need to start preparations right now. of then, what are some essential lessons learned from past vaccination programs, such , regarding thec novel use of a vaccine? dr. khan: thank you, congresswoman kuster. i think it starts with appropriate messaging. under promise, overdeliver, make sure we have excellent planning at all levels, local, national, state level, tribal and territorial level. make sure we have prioritization. not be enoughwill vaccine the moment it is released. that needs to be clear up front. part of the pla

there's a lot of factors that go into vaccine development and vaccine approval that are going to be barriers to getting the united statesat vaccinated. most of the vaccines in advanced trials right now are two-step vaccines. that's an inherent barrier to adherence because you have to get people to come out that not only once to get the vaccine, but twice to get the second dose. not only that, but the vaccines we're looking at right now, are needing to be stored at sub-zero temperatures. that's another barrier to distributions of the vaccine. once a vaccine say proved, we may only get a few hundred thousand or a few million units and those are going to the most vulnerable populations, seniors and those in nursing homes. we won't get the majority of the population vaccinated until it's approved. >> i keep telling people that it will be two years until it's normal. there's friends making winter plans, based on the vaccine that they think is coming out soon. it's not going to be all that soon. >> it's not going to be that soon. we need to understand that what we're going through is the new normal. >> thank you for that upli

a quarter corona virus infections of past 8000000 in the united states but there is new hope a vaccine could be available by the end of the year drug giant pfizer says it could file for regulator be approval next month. polls have just closed in new zealand's election opinion polls give prime ministers this into a down a 2nd time more than half of the 3500000 eligible voters cost early ballots ahead of saturday's election new zealanders were also voting on referendums to legalize euthanasia and recreational cannabis official results will be announced on the 6th of november and those are the headlines the news continues here on al jazeera after witness good buy. can i just think it's just. how long have you been here. close to. 2 years of time what's. your convict now story mind you. treat isn't a month will be every month in this point of. war you're facing what's what's. good at your brain what. you've been in contact with the family out there all of you been money is there. anything that i missed some one more than that and. that's been our quite some time . 6 months it was just it c

and come up with a cure for cancer as well as a cure for covid-19, before the united states, believing that a chinese vaccinety to the united states. >> i have little doubt that the chinese intelligence services are actively trying to steal america's intellectual property, as it relates to the virus that they unleashed on the world because of course they want to be the country that claims credit for finding those drugs or finding a vaccine and then use it as leverage against the rest of the world. maria: china's disturbing actions during this deadly disaster has left us wondering how will the united states respond? >> i have said for sometime the single geopolitical threat to the united states in the next century is china. that's true economically. it is true militarily. it is true politically. >> this is really a five or ten year success story for china. they are deeply embedded in us in almost every possible way. maria: american legislatures are not lying dormant in all of this. there are more than 60 bills in congress right now trying to hold china accountable for its actions. and the state of missouri fi

united states. as for stanford it says it has several other potential vaccine trials in the pipeline with pfizer. >>> if you're looking to pay less in rent you may be interested in three bay area counties seeing the largest drop in rents nationwide. a new report from realtor.com says rents for a two-bedroom apartment in san francisco plunged more than 21% year to year. the median rent for a two bedroom is just more than $3,900. the report says most big cities are seeing a drop in rents while outlying areas are experiencing an increase. cloud storage company drop box

storage is related to pfizer and madonna both talking about x number of millions available vaccines for the united states in total. by the way our internal documents to give you a perspective full transparency. by no means i don't want people to run with this number. for planning purposes we will provide an estimate -- just an estimatean estimate to put in perspective the high-end estimate for planning purposes for vaccination a and b. the cumulative total number of vaccinations for the nation for planning purposes on the high- end through the end of the calendar year was 45 million. note each vaccination needs to be used -- rather each distribution of vaccination has to occur in a 21 day period. you have to have two shots not one. from a logistics perspective from a storage perspective, a requirement for notification. bringing people back after the first immunization shop you can take that number and cut it in half and take a percentage of any given state including california. you get a sense for a state like ours. 1 million-2 million people topped we have roughly that in our healthcare delivery system

vaccine trials. right now more than 100 children are part of the united states first ever vaccine trial for a covid-19cine for minors. you see some of them on the screen here. how are they doing? how safe is the trial? we'll ask one of the doctors leading the research next. ♪ you can go your own way ♪ go your own way your wireless. your rules. only xfinity mobile lets you choose shared data, unlimited or a mix of each. and switch anytime so you only pay for the data you need. switch and save up to $400 a year on your wireless bill. with the carrier rated #1 in customer satisfaction. call, click, or visit your local xfinity store today. >>> so the first covid-19 vaks seen trial in the u.s. to include children is now ongoing and they're pushing for volunteers. a team at cincinnati's children hospital said it has vaccinated children in the younger age group, some as young as 12 years old. >> and then they -- >> i'm just hoping that they can use whatever they get from me and that it helps them put out a vaccine as soon as possible. >> dr. robert frank is with me. he's a pediatric vaccine specialist and di

access to all vaccines that are efficient and safe health is a big arrested an ideological electoral disputes brazil is in an awful situation 150000 coronavirus dead 2nd only to the united states things on pretty that korea's lives the economy and the election all hinge on that vaccine no wonder trump has been flooding pharmaceutical jobs 7 with billions of them to do foster and foster we have a vaccine that's coming it's ready it's going to be announced within weeks and it's going to be delivered we have operation work speed which is the military is going to distribute the vaccine and just as in brazil there's a divide a chasm in opinion people want need a vaccine but they want one that works not one that makes the most money not $1.00 that stumbled and struggled through trials and especially not one made to save the president's korea he sed this is the same fellow told you this is going to end by easter last time is the same fellow who told you that don't worry we're going to end this by the summer we're about to go into a dark winter i think it's going to be a very skeptical american public about taking apart scene and it should be if the doctors tell us that we should take

vaccine makers astrazeneca and johnson & johnson say their coronavirus trials in the united states willrs gave them the all clear. it follows reports of illnesses among the trial participants. no links to the vaccines were found. the united states has condemned turkey for testing their russian—made s—400 missile defence system. turkey's president recep tayyip erdogan confirmed the test but said he was not bound by what the us thought on the matter. the pentagon has threatened turkey, which is a nato member, with serious consequences. and a nasa space probe which slammed into an asteroid on tuesday in order to collect a sample of rock is at risk of losing its consignment. the team in charge of the spacecraft said excess rock fragments had wedged open the lid of the collector and particles were drifting off into space. governments across europe are sounding the alarm as the continent suffers a sharp increase in coronavirus infections, with several countries reporting infection rates higher than during the first wave of the pandemic in march and april. italy has recorded more than 19,000 n

and i think when we're looking at vaccinating the entire united states, we need a robust plan, we need people to raise their hand to want to do this, which i think you have a willing health care supply chain to do this. it's just a matter of coming collaborative lu together, to communicate amongst each other and execute on a plan we can all agree upon in order to get the vaccine the patients. not just to approval, but to patients, is what we need to focus on. >> thank you. dr. sharpstein, i think one of the realities of what we're seeing is we're seeing incredible time pressure put on science, put on the industry, put on the innovators that are out there trying to both discover a vaccine, but then manufacture and distribute it. and at the same time, we see a lot of politicking. this is a time, you know, of an election. and there are concerns really about trusting the science, being able to get the leeway it needs to produce what it should do, or are we taking shortcuts. i know you have thoughts on this, on pressure on the fda and others. i guess i'll ask you a similar question, is shou

of vaccine ready for distribution this year brand and what are we seeing with vaccine development outside of the united states so chinese pharmaceutical companies can see no bio logic's soon evolve and soon a farm there all release are called in 1000 vaccine but for a limited use so people who have gotten out already have been the chinese military and some chinese front line workers but nothing will be distributed in mass scale until mid 2021 then we have russia that's working not just on a 1st but a 2nd coronavirus vaccine now after they announced in august that they had come up with the world's 1st vaccine that's the sputnik v. now even though medical experts did raise some concern about just how quickly russia approved the sputnik the moscow is going forward with trials and the mass distribution plan but as of right now nothing from any country or any company that's ready for mass production in 2020 brant. r.t. correspondent saya tablature thank you for bringing us the latest and time out for a quick break but hang here because when we return tensions are on the rise between the european union and the unit

recorded coronavirus infections have passed 8 million in the united states but there is hope a vaccinee by the end of the year. pfizer's as a could file for regulator approval next month. those are the headlines. the news continues. >> held for over three years in an egyptian prison cell, denied the right to a fair trial, no charges have been brought against al jazeera correspondent --. kiss crime, journalism -- his crime, journalism. to demand his release and avoid solidarity, signed a position -- joint solidarity, signed the petition. freedom. ♪ [honking] ♪ [indistinct conversation] >> [speaking foreign language] >> [speaking foreign language] ♪ >> my name is --, i am only 18. i never was expecting to arrive down here, you know. >> [speaking foreign language] >> i do not have any memories of being here when i was young. >>[indistinct conversation] ♪ done with the united states and it is sad how i left everything behind. i do not know what i will do when i am here. ♪ >> [speaking foreign language] >> [speaking foreign language] >> [speaking foreign language] j>> [speaking foreign lang

outside the norm but not daily and we are looking at vaccinating the entire united states would need a robust plan. we need people who want to do this and we need a willing supply chain to this but it's a matter of becoming collaborative together communicate to each other and execute on a plan we can all agree upon to get the vaccine to the patients not just to approval but to the patients. >> thank you. dr. sharfstein one of the realities we are saying is we are seeing incredible time pressure put on science, but on the industry and the innovators that are out there trying to discover a vaccine but then manufacture and distribute it and at the same time we fill a lot of politics and this is the time of an election. there are concerns really about trusting is the science getting the leeway it needs to produce what it should do or are we taking shortcuts? i know you have balked on this on pressure on the fda but another question is should we be ablest to trust with developing? >> trust comes from expertise and knowing people who know what they are doing are making good decisions. it c

we will likely be able to start vaccinating people we'll be able to vaccinate everybody in the united states. but you could start vaccinating people like health care workers who need vaccine because they're putting themselves in harm's way by taking care of sick people as well as people who are vulnerable to the deleterious affects of infection like people with underlying conditions. the elderly et cetera. >>asked if he would be confident enough in the vaccine too get a shot in january fauci said if it's available. yes, i will. >>definitely. that whole week leading up to. giving birth a. emotional because those end of march beginning of april there still wasn't that much. information there are just so many unknowns. >>yeah giving birth with covid-19 a dicey time a first time mom. she tested positive for the virus just days before her baby's due date and now she's participating in the ucsf study on pregnant women with coronavirus she shares her story with kron four's michelle kingston. >>so it started out with dry cough for 2 days and then i woke up and congested rachel cliff symptoms are sim

vaccines. we need to make sure that when people get sick that they have the kind of therapies at the president of the united states thosehat we can provide emergency youth authorizations. on ae very hopeful, based number of conversations that vaccines are just a few weeks away. we are in preparation for that. yet, at the same time, a national lockdown strategy or a strategy israntine not effective, that is not will ultimately contain or control this virus. any suggestion that we are waving the red flag, the white flag is not in keeping with this president. you know him, he does not give up. he would not give up until all americans are safe. >> will president trump be in georgia tomorrow? -- senatork marrows mark meadows: it will be in uphill battle for joe biden. we will win my home state of north carolina, we will win florida. joe biden is starting to come out and campaign. there should be panic for him. we are crisscrossing all over this country. we are asking the american do the best weus can to make a compelling case that there is one candidate in this race that will put america first. that is the president of

to the news from astrazeneca, for example, that illustrates vaccine tri -- its vaccine trial will resume in the united statesfter safety concerns. you're a true expert in this field. what do you think? >> well, wolf, it's a sigh of relief. whenever we develop vaccines for anything, when we get into larger clinical studies, we are always going to find something that happens in a person and we have to stop and investigate whatever happens and determine if it was related to the vaccine or not. and determine if it poses some risk that will be greater than the benefit that we would see if we had a vaccine for that particular disease target. it sounds like the fda to their time to review this. astrazeneca provided the information and data it needed for the updated review. with the fda giving a green light to continue in that clinical trial tells me they are going to continue watching and monitoring closely for any similar events such as what they have seen already. however, the fda must be comfortable that either the event was rare or unsignificant for whatever they investigated and/or the company has a really str

one of the reasons so many countries are looking to china for this vaccine is because the other world superpowers come the united statested states has not even joined the international facility to prioritise manufacturing and sharing vaccines once they are available. countries very much looking to china and the tickets in best interest particularly in tunisia or india where the pandemic is so severe. gives a sense of how this is being viewed in china. in china i think there are a lot of questions. of course people want china to have the vaccine first, they wanted to be shared as well. they see it is good for the chinese reputation and for china taking its place back of the world stage. at the same time a lot of trials are happening and of course there are concerns that these vaccines are not ready yet. the issue here is that in china the country is basically getting covid—19 under control entirely. you might disagree with the measures taken to do that but that's the facts now. we need for the vaccine is not as important there as perhaps it is in other countries. it is a lot of value seen by people in providing a public

one of the reasons so many countries are looking to china for this vaccine is because the other world superpowers come the united statesined the international facility to prioritise manufacturing and sharing vaccines once they are available. countries very much looking to china and the tickets in best interest particularly in tunisia or india where the pandemic is so severe. gives a sense of how this is being viewed in china. in china i think there are a lot of questions. of course people want china to have the vaccine first, they wanted to be shared as well. they see it is good for the chinese reputation and for china taking its place back of the world stage. at the same time a lot of trials are happening and of course there are concerns that these vaccines are not ready yet. the issue here is that in china the country is basically getting covid—19 under control entirely. you might disagree with the measures taken to do that but that's the fa cts taken to do that but that's the facts now. we need for the vaccine is not as important there as perhaps it is in other countries. it is a lot of value seen by people in provi

if we are looking at vaccinating the entire united states, we need a robust plan and people to raise their hand and i think if you have a willing healthcare supply chain to do this it is just a matter of becoming collaborative together, communicate amongst each other and have a plan we can all agree upon to get the vaccine to the patient's not just the approval, but to patients is what we need to focus on. >> one of the reality is w reale seeing is incredible time pressure put on science and the industry and innovators to discover the vaccine and then manufacture and distribute it. there are concerns about trusting giving the legal way that it needs to produce what it should do. what are your thoughts they will last a similar question should we all be able to trust what is developing? >> i think trust comes from expertise. knowing people who know what they are doing or making the decisions that come from the data and transparency. it doesn't come from political interference that undermines trust. so, i think that we are poised to have a vaccine and a good review process and independe

how do you ensure equitable access to a vaccine within the united states and globally?ac >> i will be brief here because the expert on this is tom , he's the expert on seen nationalism but our report does talk about the importance of supporting an international mechanism that that position on equity built into it based on public health and not simply trying to lock up supplies for citizens but calm, i think you see to that. >> thank you for that and it's a great question. we are weeks and potentially months away from a vaccine. there is a hsmultilateral initiative that the report report seeks to supporting two share vaccines. it is being led world health organization and partners. that said, many wealthy nations are engaging in advanced purchase agreements which are inherently libelous . >> we now leave this program for what's expected to be a short senate pro forma session with no legislative business. >>

, first week of december or something like that, so we have this vaccine and now we have get to do 330 million people in the united states who want it. what are going to be the issues there? >> so there's a whole series of issues about who gets it first. and understand all the vaccines we're talking about are two-dose vaccines. so you have to get two doses either 21 or 28 days apart. so if you produce 100 million ds that's enough for 50 million people, which is enough for, you know, some like 7.5 million people in california. you have 15% of the population. so who are those people? who's going to get it first? well, clearly people who are facing patients. so the intensive care units, emergency departments, urgent care, clinical settings, emts, nursing home and long-term care facility staff, especially important. those are the people who are going to get it first. and then we're going to move out to essential workers however they be defined. so that's probably going to be defined as police, fire, public safety kinds of things. but, you know, to me i think the guys picking the food in the fields are essential workers, too.

afternoon about covid vaccines both as zen ka and johnson and johnson said their vaccine trials are resuming in the united states. they had been put on hold. going back to september after some events in the trial, they said the fda reviewed all data and said it is safe to resume the trial. they said they expect the trial later this year. the company is saying it's ready to resume recruitment in the united states and that's after independent data and safety board recommended resuming the trial in consultation with the fda. they say no clear cause has been identified the company found no evidence that the vaccine candidate caused the event the company going further and saying they don't know if the participant was on the vaccine or placebo but we would assume if it was on the placebo we could have known sooner it took about 10 to 14 days. >> they still hope to get data by the end of the year remember, this trial only requires one shot of the vaccine versus all of the others in the leadup which require two shots so they should be able to garner data faster in the trial and there are 60,000 people around the world.

vaccine quickly. >> the president of the united states has promoted unproven miracle cures. >> if we don't restore public confidence in this all of the people told us they are not going to take the vaccine. >> they argued the evidence of mistrust is building and pointed to the responses by a third of people in a recent poll. >> endorsed a statement saying it is definitely or probably true that the vaccine's harmful effects are not being disclosed. >> the committee has the responsibility of pouring over data. the advisory committee includes experts in the field. >> the keyword is advisory. the government doesn't have to take any of the recommendations officially. >> with the pressures from the vaccine rivalled by demands for transparency an obscure fda committee will be working in a very bright spotlight. >> your health is one of the pillars of building a better bay area. as san francisco yadvanced to te yellow tier more businesses have been allowed to reopen but some forced to close. a youth dance class that is facing a tough decision. >> reporter: city ballet san francisco has operated indoors without i

vaccine quickly. >> the president of the united states has promoted unproven miracle cures. >> if we don't restore public confidence in this all of the people told us they are not going to take the vaccine. >> they argued the evidence of mistrust is building and pointed to the responses by a third of people in a recent poll. >> endorsed a statement saying it is definitely or probably true that the vaccine's harmful effects are not being disclosed. >> the committee has the responsibility of pouring over data. the advisory committee includes experts in the field. >> the keyword is advisory. the government doesn't have to take any of the recommendations officially. >> with the pressures from the vaccine rivalled by demands for transparency an obscure fda committee will be working in a very bright spotlight. >> your health is one of the pillars of building a better bay area. as san francisco yadvanced to te yellow tier more businesses have been allowed to reopen but some forced to close. a youth dance class that is facing a tough decision. >> reporter: city ballet san francisco has operated indoors without i

but at least from the united states perspective, i think there's no doubt that we are in the middle of a political debate,, and unfortunately, that has made huge impacts on vaccine nedistribution here in the u.s.s well as in the world. the united states has withdrawn from our leadership effort with equitable distribution worldwide. we are threatening with the administration to pull out of the who which is a critical platform for transparency and distribution. we have not participated in the large funding conferences that have occurred with our neighbors in europe and others to look at investing in equitable distribution and manufacturing ctand i would say also even with the post 2017 organization focused on a coalition, focused on epidemicio preparedness, congress hasn't really invested. we put a total of $20 million into that entity. but currently it is proceeding with investment in nine vaccine candidates. the u.s. and the u.s. centric warp speed is only investing in six of those. so we have the possibility in the united states to be at the back of the line if one of the otherf three is actually the first to show effectiveness and safety. so not only are we no

the significance is that, hey, the very first trial that started in the united states for a covid vaccine in rolled all of its people. they have given them all their first shots, given nearly all of them their second shots. that tells us things are moving. however, it does not tell us we will have a vaccine on the market any time soon, because just because they gave people shots, it doesn't mean the vaccine actually works. so let's take a look at some of the details here. as of this morning moderna enrolls all 30,000. half got the vaccine, half got placebo. nobody knows, participants don't know, doctors don't know, moderna don't know. once 53 participants get sick with covid, a safety board will unblind it. of those 53 if fewer than 14 received the vaccine, 25% or fewer received the vaccine, then moderna will ask the fda for an emergency use authorization. jake. >> so that's 53 participants getting coronavirus on their own. not that they will get infected with it like they are doing with that experiment in london. >>> today republicans on senate judiciary committee vod-of-voted to advance

after all, we are trying to vaccinate 330 million people in the united states. u can't do that in a week and a half. it will take months. as i said, some people will hang back, and the vaccine may not be perfectly effective. one of the things people haven't realized is even after you are vaccinated, you are going to have to continue to wear your mask and social distance. that will continue for many, many months. i anticipate we will be wearing masks this time next year. alix: wow. it is really good to get the perspective and put the vaccine in context. william schaffner, thank you so much. good to talk to you. this is bloomberg. ♪ ritika: it is time for the bloomberg business flash, a look at some of the biggest business stories in the news right now. i'm ritika gupta. lori l reported a surprise -- l'oreal reported a surprise increase in sales. l'oreal's ceo. mitigate trying to through this crisis, and we are still confident that we should be able to have a positive second half this year, and we are preparing also for positive and dynamic next year. ritika: bloom

on lots of issues, at least from the united states perspective i think there is no doubt that your middle of a political debate. that has a huge impact on vaccines distribution in the u.s. as well as in the world, the united states has withdrawn from our leadership effort with equitable distribution worldwide, we are threatening with this administration to pull out of the w.h.o. which is a critical platform for transparency and distribution, we have not participated in two of the large funding conferences that have occurred for our neighbors in europe and others to look at investing in equitable distribution and manufacturing i would say also with the post-2017 organization focused on a coalition focused on academic preparedness congress has not invested, we put a total of $20 million into the entity but it currently is proceeding with investment and nine vaccine candidates, the u.s. and our u.s. centered warp speed is only investing in six of those, we have a possibility in the united states to be at the back of the line if one of the other three is actually the first to show effectiveness and safety, not only are we not providing leadership in